Clinical Trial Update: A Phase I/II Study of JL19001 Injection Alone or in Combination With BCG in Subjects With High Risk Non-Muscle Invasive Bladder Cancer. [Phase 1]

View source ↗

Summary

This is a registry entry for a Phase I/II study evaluating JL19001 injection alone or in combination with BCG in patients with high-risk non-muscle invasive bla…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-muscle Invasive Bladder Cancer

Drugs mentioned

• BCG (Bacillus Calmette-Guérin)
• JL19001

Snippet

Sponsor: Jecho Biopharmaceuticals Co., Ltd. | Conditions: High Risk Non-muscle Invasive Bladder Cancer | Phase 1 | Status: NOT_YET_RECRUITING